Replies to post #125135 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

Seems to fit here, IMO..

• Comparison of Case-mix in Multiple Sclerosis Patients Participating in Randomized Control Trials, Prospective Observational Studies, and Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) – Poster P351 – Thursday, 26 October, 15:30-17:00 CET